DEXCOM INC DXCM
DEXCOM INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($17.85); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
DEXCOM INC trades at about 43.4× earnings — below its 10-year norm (10-year range 34.9×–218.9×, median 93.3×).
Shaded band = 10-year range (34.9×–218.9×); dot = today's 43.4×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | 68.5% | 66.0% |
| Operating margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | -5.9% | -11.1% |
| Net margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | 28.5% | 6.8% | -12.3% | -7.0% | -11.4% |
| FCF margin | 23.1% | 15.6% | 14.1% | 10.5% | 2.2% | 14.4% | 9.1% | 5.4% | 3.6% | 0.1% |
| Return on assets | 13.2% | 8.9% | 8.6% | 6.3% | 4.4% | 12.8% | 4.2% | -6.6% | -5.6% | -16.3% |
| Return on equity | 30.5% | 27.4% | 26.2% | 16.0% | 10.6% | 30.1% | 11.5% | -19.2% | -12.0% | -23.1% |
| Current ratio | 1.88 | 1.47 | 2.84 | 1.99 | 5.11 | 5.58 | 5.47 | 7.64 | 5.36 | 2.73 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.